top of page
Search

Revolutionizing Immune Research: Measuring FHR Proteins Across the SciFiMed Universe! 🧬✨🌌

Join Mara van Rossum, Bert Veuskens, Richard Pouw, Erik Toonen, and an international crew of pioneering researchers as they unveil a galaxy of groundbreaking assays, accurately measuring key immune regulators—the Factor H-related (FHR) proteins—in human blood. Validated across the entire SciFiMed network, this interstellar effort takes science to new frontiers! 🌍🔬🌠


🛡️ Why Should You Care About FHR Proteins?

Our immune defense relies on the complement system—think of it as your body's guardian system protecting health and balance. Factor H (FH) and its close cousins, the Factor H-related proteins (FHR-1 to FHR-5), play mysterious yet vital roles. However, precise measurements have long eluded researchers, keeping their exact functions hidden in the shadows—until now! 🔍🧩✨


🛰️ What’s the Big Discovery?

Researchers have successfully crafted highly specialized lab tests (ELISAs), powered by uniquely tailored monoclonal antibodies 🧪🧫. These revolutionary assays detect and quantify individual FHR proteins (FHR-2, -3, -4, and -5) with unmatched precision.


🌟 🚀 The SciFiMed Advantage – Cross-Galactic Validation:

  • 🏆 Inter-laboratory Excellence: Uniquely validated across multiple labs within the SciFiMed Consortium, ensuring universal accuracy and reliability.

  • 🛰️ Universal Standards: Setting a groundbreaking benchmark through coordinated validation!


📌 Key Galactic Achievements:

  • ✅ Developed precise monoclonal antibodies targeting FHR-2, -3, -4, and -5.

  • ✅ Established robust, universally reliable ELISA tests.

  • ✅ Verified unmatched reproducibility across numerous SciFiMed labs.


Why Is This Mission Critical?

These assays unlock the door for large-scale clinical research and reliable diagnostics, helping us better understand and treat immune-system-related diseases, including vision-threatening conditions like age-related macular degeneration (AMD) and kidney diseases. 🩸👁️🧬


🌟 Final Frontier:

A landmark step in complement research—boldly validated across an entire constellation of labs—moving us toward improved health and personalized medicine. 🚀🧑‍🚀🌠



 
 
 

Recent Posts

See All

Comments


flag_yellow_high.jpg

This project has received funding from the European Union’s Horizon 2020

research and innovation programme under grant agreement No 899163

  • LinkedIn

©2020 by SciFiMed.

bottom of page